- Investing Ideas
- Australian Healthcare Undervalued over 20% based on DCF
Australian Healthcare Undervalued over 20% based on DCF
Results
6
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
6 companies
Ramsay Health Care
Market Cap: AU$8.6b
Owns and operates hospitals in Australia and internationally.
RHC
AU$37.00
7D
-1.9%
1Y
2.3%
Cochlear
Market Cap: AU$6.4b
Provides implantable hearing solutions for children and adults worldwide.
COH
AU$97.40
7D
0.5%
1Y
-63.9%
Ansell
Market Cap: AU$3.8b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$27.07
7D
3.8%
1Y
-14.0%
Integral Diagnostics
Market Cap: AU$774.8m
A healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
IDX
AU$2.12
7D
5.5%
1Y
-13.5%
Cogstate
Market Cap: AU$445.4m
A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.
CGS
AU$2.60
7D
2.4%
1Y
98.5%
SomnoMed
Market Cap: AU$120.5m
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.
SOM
AU$0.57
7D
3.6%
1Y
-0.4%